ABCB9 anticorps (N-Term)
-
- Antigène Voir toutes ABCB9 Anticorps
- ABCB9 (ATP-Binding Cassette, Sub-Family B (MDR/TAP), Member 9 (ABCB9))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat, Porc, Boeuf (Vache), Chien, Cobaye, Lapin
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ABCB9 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- RLWKAVVVTL AFMSVDICVT TAIYVFSHLD RSLLEDIRHF NIFDSVLDLW
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 75%, Human: 100%, Mouse: 100%, Pig: 93%, Rabbit: 93%, Rat: 100%
- Attributs du produit
- This is a rabbit polyclonal antibody against ABCB9. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human ABCB9
- Top Product
- Discover our top product ABCB9 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 723 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
The effect of caveolin-1 (Cav-1) on fatty acid uptake and CD36 localization and lipotoxicity in vascular smooth muscle (VSM) cells." dans: International journal of physiology, pathophysiology and pharmacology, Vol. 1, Issue 1, pp. 1-14, (2011) (PubMed).
: "
-
The effect of caveolin-1 (Cav-1) on fatty acid uptake and CD36 localization and lipotoxicity in vascular smooth muscle (VSM) cells." dans: International journal of physiology, pathophysiology and pharmacology, Vol. 1, Issue 1, pp. 1-14, (2011) (PubMed).
-
- Antigène
- ABCB9 (ATP-Binding Cassette, Sub-Family B (MDR/TAP), Member 9 (ABCB9))
- Autre désignation
- ABCB9 (ABCB9 Produits)
- Synonymes
- anticorps ABCB9, anticorps si:dkey-21k4.3, anticorps EST122234, anticorps TAPL, anticorps mKIAA1520, anticorps Tapl, anticorps ATP binding cassette subfamily B member 9, anticorps ATP-binding cassette, sub-family B (MDR/TAP), member 9, anticorps ABCB9, anticorps abcb9, anticorps Abcb9
- Sujet
-
ABCB9, a membrane-associated protein, is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABCB9 is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. The function of this half-transporter has not yet been determined, however, this protein may play a role in lysosomes.The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. The function of this half-transporter has not yet been determined, however, this protein may play a role in lysosomes. Alternative splicing of this gene results in distinct isoforms which are likely to have different substrate specifications.
Alias Symbols: EST122234, KIAA1520, TAPL
Protein Interaction Partner: UBC,
Protein Size: 723 - Poids moléculaire
- 80 kDa
- ID gène
- 23457
- NCBI Accession
- NM_019624, NP_062570
- UniProt
- Q9NP78
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-